Pinnacle Wealth Planning Services Inc. Purchases 558 Shares of Zoetis Inc (NYSE:ZTS)

Pinnacle Wealth Planning Services Inc. boosted its position in shares of Zoetis Inc (NYSE:ZTS) by 13.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,802 shares of the company’s stock after acquiring an additional 558 shares during the period. Pinnacle Wealth Planning Services Inc.’s holdings in Zoetis were worth $598,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Bath Savings Trust Co grew its stake in shares of Zoetis by 26.0% in the 2nd quarter. Bath Savings Trust Co now owns 7,293 shares of the company’s stock valued at $828,000 after purchasing an additional 1,505 shares during the period. Park National Corp OH boosted its holdings in shares of Zoetis by 4.0% in the 2nd quarter. Park National Corp OH now owns 110,650 shares of the company’s stock worth $12,558,000 after acquiring an additional 4,271 shares in the last quarter. Private Trust Co. NA boosted its holdings in shares of Zoetis by 3.7% in the 2nd quarter. Private Trust Co. NA now owns 15,519 shares of the company’s stock worth $1,761,000 after acquiring an additional 556 shares in the last quarter. Dorsey Wright & Associates boosted its holdings in shares of Zoetis by 7.6% in the 2nd quarter. Dorsey Wright & Associates now owns 4,593 shares of the company’s stock worth $521,000 after acquiring an additional 324 shares in the last quarter. Finally, WINTON GROUP Ltd boosted its holdings in shares of Zoetis by 2.3% in the 2nd quarter. WINTON GROUP Ltd now owns 7,534 shares of the company’s stock worth $855,000 after acquiring an additional 171 shares in the last quarter. Hedge funds and other institutional investors own 90.07% of the company’s stock.

ZTS has been the topic of several recent analyst reports. Stifel Nicolaus set a $140.00 target price on Zoetis and gave the stock a “buy” rating in a report on Friday, September 13th. Goldman Sachs Group initiated coverage on Zoetis in a report on Monday, September 9th. They issued a “conviction-buy” rating and a $145.00 target price on the stock. Morgan Stanley boosted their target price on Zoetis from $100.00 to $136.00 and gave the stock an “equal weight” rating in a report on Monday, September 30th. SunTrust Banks boosted their target price on Zoetis from $120.00 to $130.00 and gave the stock a “hold” rating in a report on Tuesday, August 13th. Finally, Argus set a $140.00 target price on Zoetis and gave the stock a “buy” rating in a report on Wednesday, September 4th. Eight equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. Zoetis has an average rating of “Buy” and an average target price of $125.20.

In other Zoetis news, EVP Kristin C. Peck sold 11,500 shares of the company’s stock in a transaction on Monday, August 12th. The shares were sold at an average price of $123.22, for a total transaction of $1,417,030.00. Following the completion of the sale, the executive vice president now owns 48,877 shares in the company, valued at approximately $6,022,623.94. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Clinton A. Jr. Lewis sold 6,123 shares of the company’s stock in a transaction on Wednesday, August 14th. The shares were sold at an average price of $123.51, for a total transaction of $756,251.73. Following the sale, the insider now owns 44,255 shares of the company’s stock, valued at approximately $5,465,935.05. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 34,332 shares of company stock worth $4,258,182. Company insiders own 0.29% of the company’s stock.

NYSE:ZTS traded down $2.58 during trading hours on Friday, hitting $125.34. 2,198,613 shares of the stock were exchanged, compared to its average volume of 1,862,721. The company’s 50 day moving average is $125.40 and its two-hundred day moving average is $115.68. Zoetis Inc has a twelve month low of $78.90 and a twelve month high of $130.20. The company has a quick ratio of 2.87, a current ratio of 4.17 and a debt-to-equity ratio of 2.74. The company has a market capitalization of $61.09 billion, a P/E ratio of 40.04, a price-to-earnings-growth ratio of 3.17 and a beta of 0.88.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.08. Zoetis had a return on equity of 72.86% and a net margin of 22.74%. The firm had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.51 billion. During the same quarter in the prior year, the business earned $0.77 EPS. The business’s revenue for the quarter was up 9.3% compared to the same quarter last year. On average, equities research analysts expect that Zoetis Inc will post 3.57 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Tuesday, October 22nd will be issued a dividend of $0.164 per share. This represents a $0.66 annualized dividend and a yield of 0.52%. The ex-dividend date of this dividend is Monday, October 21st. Zoetis’s dividend payout ratio is 21.09%.

Zoetis Profile

Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

Featured Article: Blockchain

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.